Oral Histone Deacetylase Inhibitor Receives FDA Fast Track Designation for PV | Docwire News
The agent targets abnormal gene expression in order to control the excessive cell proliferation that occurs in PV.
Related Articles
Study identifies nonmutational p53 dysfunction as MDS risk factor – SOHO Insider
Even in patients with myelodysplastic syndromes (MDS) who don’t have a mutation in tumor protein 53 (p53), the p53 protein might still be dysfunctional, according…
Tailoring Myelofibrosis Care With the Latest Molecular Discoveries | Blood Cancers Today
Experts explore advances in the molecular understanding of myelofibrosis, focusing on key mutations, diagnostic tools, and treatment innovations.
The Cancer Nursing Today CARE Award | Cancer Nursing Today
Nurses: Nominate your oncology nursing peers and colleagues who demonstrate resilience, role modeling, and high-level patient care for the inagural CNT CARE Award.
Open Comment of Guidelines – ASCO
Open comment allows key stakeholders to critically review and identify any errors or gaps in a draft guideline prior to its finalization and publication. It…
Cutaneous Melanoma: Sun Protection Behaviors and UV Exposure in Canada | Docwire News
A troubling rise in sun exposure and inconsistent sunscreen use may be linked to incidence of skin cancer in Canada.
The Uromigos Episode 413: The Uromigos Score for Advanced Prostate Cancer | GU Oncology Now
Returning guests Drs. Silke Gillessen and Chris Sweeney join the podcast to discuss the Uromigos Score, in which experts score the value of treatments for…
Cardiovascular Disease After Hematopoietic Stem Cell Transplantation in Adults: JACC: CardioOncology State-of-the-Art Review
AbstractThe use of hematopoietic cell transplantation (HCT) has expanded in the last 4 decades to include an older and more comorbid population. These patients face…
Sudden Cardiac Arrest in a Young Male: The Role of Intraplaque Hemorrhage and Coronary Spasm
AbstractBackgroundSudden cardiac death (SCD) is commonly linked to coronary artery disease (CAD), often involving plaque rupture or erosion. Intraplaque hemorrhage (IPH) has emerged as a…
Effect of ANGPTL3 Inhibition With Solbinsiran in Preclinical and Early Human Studies:
AbstractBackgroundThe residual cardiovascular risk associated with hypertriglyceridemia and remnant particles supports efforts to develop effective novel therapeutic approaches. Angiopoietin-like p…